The Food & Drug Administration has updated the Mammography Quality Standards Act (MQSA) to make patient breast density notification a federal requirement.
Cancer Risk
Breast Density
Dense breast tissue is common but linked to an increased risk for breast cancer. As density increases, mammography accuracy decreases.
![Spotlighting breast density](https://www.volparahealth.com/app/uploads/2021/09/spotlight-density-800x0-c-default.png)
What you need to know
Patients
Required "inform" language
Mammography summary lay letter must inform patient if they have dense or non-dense breast tissue.
Providers
Assessment in referring provider reports
Reports for healthcare providers must include an assessment of breast density using the BI-RADS® 5th Edition categories.
Quick Guide
FDA ruling summary, checklist, and Volpara support.
Get ready now
Your checklist for compliance by September 2024
![](https://www.volparahealth.com/app/uploads/2023/09/Eye-icon-card.png)
Review MQSA rule update
![](https://www.volparahealth.com/app/uploads/2023/09/Info-icon-card.png)
Contact the MQSA program for assistance
![](https://www.volparahealth.com/app/uploads/2023/09/Shield-icon-card.png)
Consider state-level language for insurance coverage